Cell-state dynamics and therapeutic resistance in melanoma from the perspective of MITF and IFNγ pathways
出版年份 2019 全文链接
标题
Cell-state dynamics and therapeutic resistance in melanoma from the perspective of MITF and IFNγ pathways
作者
关键词
-
出版物
Nature Reviews Clinical Oncology
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2019-04-10
DOI
10.1038/s41571-019-0204-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress
- (2018) Jennifer Tsoi et al. CANCER CELL
- Rituximab as a therapeutic option for patients with advanced melanoma
- (2018) Julia K. Winkler et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Mechanisms of Resistance to PD-1 and PD-L1 Blockade
- (2018) Theodore S. Nowicki et al. CANCER JOURNAL
- Toward Minimal Residual Disease-Directed Therapy in Melanoma
- (2018) Florian Rambow et al. CELL
- Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study
- (2018) Sara Valpione et al. EUROPEAN JOURNAL OF CANCER
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway
- (2018) Xuerong Sun et al. Cell Death & Disease
- Immunotherapy Resistance by Inflammation-Induced Dedifferentiation
- (2018) Arnav Mehta et al. Cancer Discovery
- Abstract CT176: Effect of JAK/STAT or PI3Kδ plus PD-1 inhibition on the tumor microenvironment: Biomarker results from a phase Ib study in patients with advanced solid tumors
- (2018) John M. Kirkwood et al. CANCER RESEARCH
- Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma
- (2017) Paola Falletta et al. GENES & DEVELOPMENT
- Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy
- (2017) Cristina Maccalli et al. IMMUNOLOGICAL INVESTIGATIONS
- Cancer Stem Cells (CSCs) in melanoma: There's smoke, but is there fire?
- (2017) Constance E. Brinckerhoff JOURNAL OF CELLULAR PHYSIOLOGY
- An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition
- (2017) Helen L. Young et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Recent Advances in Melanoma and Melanocyte Biology
- (2017) Hensin Tsao et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Notch3 signaling-mediated melanoma–endothelial crosstalk regulates melanoma stem-like cell homeostasis and niche morphogenesis
- (2017) Mei-Yu Hsu et al. LABORATORY INVESTIGATION
- Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)
- (2017) Jacob Schachter et al. LANCET
- Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma
- (2017) Dhiraj Kumar et al. Molecular Cancer
- Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly dividing de‐differentiated state
- (2017) Mohammad Fallahi‐Sichani et al. Molecular Systems Biology
- Cancer drug addiction is relayed by an ERK2-dependent phenotype switch
- (2017) Xiangjun Kong et al. NATURE
- Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance
- (2017) Sydney M. Shaffer et al. NATURE
- Identification of essential genes for cancer immunotherapy
- (2017) Shashank J. Patel et al. NATURE
- Tumour ischaemia by interferon-γ resembles physiological blood vessel regression
- (2017) Thomas Kammertoens et al. NATURE
- In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
- (2017) Robert T. Manguso et al. NATURE
- Tumour heterogeneity and resistance to cancer therapies
- (2017) Ibiayi Dagogo-Jack et al. Nature Reviews Clinical Oncology
- Genetic variation in IRF4 expression modulates growth characteristics, tyrosinase expression and interferon-gamma response in melanocytic cells
- (2017) Yash Chhabra et al. Pigment Cell & Melanoma Research
- Interferon-γ is a master checkpoint regulator of cytokine-induced differentiation
- (2017) Zhao Zha et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance
- (2017) Yapeng Su et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clonal cooperativity in heterogenous cancers
- (2017) Hengbo Zhou et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Tumor-associated B-cells induce tumor heterogeneity and therapy resistance
- (2017) Rajasekharan Somasundaram et al. Nature Communications
- Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions
- (2017) Antje Sucker et al. Nature Communications
- Recurrent Tumor Cell–Intrinsic and –Extrinsic Alterations during MAPKi-Induced Melanoma Regression and Early Adaptation
- (2017) Chunying Song et al. Cancer Discovery
- The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy
- (2017) Daniel Zingg et al. Cell Reports
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF
- (2017) Mitchell E. Fane et al. EBioMedicine
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy
- (2016) Michael P. Smith et al. CANCER CELL
- Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
- (2016) Jianjun Gao et al. CELL
- Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
- (2016) Joseph L. Benci et al. CELL
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
- (2016) Willy Hugo et al. CELL
- Combination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling
- (2016) Andy J. Minn et al. CELL
- Persistence to anti-cancer treatments in the stationary to proliferating transition
- (2016) Sivan Pearl Mizrahi et al. CELL CYCLE
- MAPK Pathway Inhibitors Sensitize BRAF-Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB
- (2016) A. A. N. Rose et al. CLINICAL CANCER RESEARCH
- Simultaneous blocking of IL-6 and IL-8 is sufficient to fully inhibit CAF-induced human melanoma cell invasiveness
- (2016) Njainday Pulo Jobe et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma
- (2016) Antoni Ribas et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Activity-Based Protein Profiling Shows Heterogeneous Signaling Adaptations to BRAF Inhibition
- (2016) Ritin Sharma et al. JOURNAL OF PROTEOME RESEARCH
- Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
- (2016) Aaron N Hata et al. NATURE MEDICINE
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Both Complexity and Location of DNA Damage Contribute to Cellular Senescence Induced by Ionizing Radiation
- (2016) Xurui Zhang et al. PLoS One
- Density of immunogenic antigens does not explain the presence or absence of the T-cell–inflamed tumor microenvironment in melanoma
- (2016) Stefani Spranger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
- (2016) I. Tirosh et al. SCIENCE
- Feedback Activation of STAT3 as a Cancer Drug-Resistance Mechanism
- (2016) Chengguang Zhao et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells
- (2016) Michael Ramirez et al. Nature Communications
- Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
- (2016) Daniel Sanghoon Shin et al. Cancer Discovery
- JUN dependency in distinct early and late BRAF inhibition adaptation states of melanoma
- (2016) Bjoern Titz et al. Cell Discovery
- Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse: ‘What does not kill me strengthens me’
- (2015) A O Pisco et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK Signaling
- (2015) Eishu Hirata et al. CANCER CELL
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance
- (2015) Willy Hugo et al. CELL
- BRAF Inhibition Stimulates Melanoma-Associated Macrophages to Drive Tumor Growth
- (2015) T. Wang et al. CLINICAL CANCER RESEARCH
- Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes
- (2015) M. Freeman-Keller et al. CLINICAL CANCER RESEARCH
- A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition
- (2015) M. P. Mak et al. CLINICAL CANCER RESEARCH
- Metastatic Melanoma Cells Evade Immune Detection by Silencing STAT1
- (2015) JoDi Osborn et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Paeonol inhibits B16F10 melanoma metastasisIn vitroandIn Vivovia disrupting proinflammatory cytokines-mediated NF-κB and STAT3 pathways
- (2015) Lei Zhang et al. IUBMB LIFE
- Multiple Structural and Epigenetic Defects in the Human Leukocyte Antigen Class I Antigen Presentation Pathway in a Recurrent Metastatic Melanoma Following Immunotherapy
- (2015) Chien-Chung Chang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- BRAF Inhibition Generates a Host–Tumor Niche that Mediates Therapeutic Escape
- (2015) Inna V. Fedorenko et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation
- (2015) Martin Lauss et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- MITF Modulates Therapeutic Resistance through EGFR Signaling
- (2015) Zhenyu Ji et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Cancer Microenvironment and Endoplasmic Reticulum Stress Response
- (2015) Claudia Giampietri et al. MEDIATORS OF INFLAMMATION
- Interferon α/β Enhances the Cytotoxic Response of MEK Inhibition in Melanoma
- (2015) Oren Litvin et al. MOLECULAR CELL
- Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
- (2015) Christina Twyman-Saint Victor et al. NATURE
- Therapy-induced tumour secretomes promote resistance and tumour progression
- (2015) Anna C. Obenauf et al. NATURE
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy
- (2015) Claudia Wellbrock et al. Pigment Cell & Melanoma Research
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma
- (2015) Rachel Ramsdale et al. Science Signaling
- Cancer and the Immune System: Basic Concepts and Targets for Intervention
- (2015) Drew Pardoll SEMINARS IN ONCOLOGY
- Interferons and the Immunogenic Effects of Cancer Therapy
- (2015) Andy J. Minn TRENDS IN IMMUNOLOGY
- MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment
- (2015) Stefanie Riesenberg et al. Nature Communications
- Adaptive Immune Resistance: How Cancer Protects from Immune Attack
- (2015) A. Ribas Cancer Discovery
- Downregulation of the Ubiquitin Ligase RNF125 Underlies Resistance of Melanoma Cells to BRAF Inhibitors via JAK1 Deregulation
- (2015) Hyungsoo Kim et al. Cell Reports
- The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma
- (2015) Rachel Ramsdale et al. Science Signaling
- The mutually regulatory loop of epithelial–mesenchymal transition and immunosuppression in cancer progression
- (2015) Limo Chen et al. OncoImmunology
- Prognostic Significance of Cutaneous Adverse Events Associated With Pembrolizumab Therapy
- (2015) Jennifer A. Lo et al. JAMA Oncology
- Inducible but Not Constitutive Expression of PD-L1 in Human Melanoma Cells Is Dependent on Activation of NF-κB
- (2015) Kavitha Gowrishankar et al. PLoS One
- Secretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumor-initiating cell phenotype.
- (2015) Mickaël Ohanna et al. Oncotarget
- The role of melanogenesis in regulation of melanoma behavior: Melanogenesis leads to stimulation of HIF-1α expression and HIF-dependent attendant pathways
- (2014) A. Slominski et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Phenotype Switching: Tumor Cell Plasticity as a Resistance Mechanism and Target for Therapy
- (2014) K. Kemper et al. CANCER RESEARCH
- Cellular Differences in Protein Synthesis Regulate Tissue Homeostasis
- (2014) Michael Buszczak et al. CELL
- MITF in melanoma: mechanisms behind its expression and activity
- (2014) Mariusz L. Hartman et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Genetic Evolution of T-cell Resistance in the Course of Melanoma Progression
- (2014) A. Sucker et al. CLINICAL CANCER RESEARCH
- UV Signaling Pathways within the Skin
- (2014) Hongxiang Chen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Clonal variegation and dynamic competition of leukemia-initiating cells in infant acute lymphoblastic leukemia with MLL rearrangement
- (2014) M Bardini et al. LEUKEMIA
- Attenuation of IFN-γ-induced B7-H1 expression by 15-deoxy-delta12,14-prostaglandin J2 via downregulation of the Jak/STAT/IRF-1 signaling pathway
- (2014) Su-Kil Seo et al. LIFE SCIENCES
- Pigmentation in the sentinel node correlates with increased sentinel node tumor burden in melanoma patients
- (2014) Cornelia G.F. van Lanschot et al. MELANOMA RESEARCH
- PhiC31/PiggyBac modified stromal stem cells: effect of interferon γ and/or tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) on murine melanoma
- (2014) Vahid Bahrambeigi et al. Molecular Cancer
- Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
- (2014) Chong Sun et al. NATURE
- Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers
- (2014) Allison S. Cleary et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
- (2014) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- A stress-induced early innate response causes multidrug tolerance in melanoma
- (2014) D Ravindran Menon et al. ONCOGENE
- Cyclin-dependent kinases as therapeutic targets in melanoma
- (2014) David M. Miller et al. Pigment Cell & Melanoma Research
- Wnt5A promotes an adaptive, senescent-like stress response, while continuing to drive invasion in melanoma cells
- (2014) Marie R. Webster et al. Pigment Cell & Melanoma Research
- IFN-γ signaling maintains skin pigmentation homeostasis through regulation of melanosome maturation
- (2014) Vivek T. Natarajan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Monitoring the dynamics of clonal tumour evolution in vivo using secreted luciferases
- (2014) Joël P. Charles et al. Nature Communications
- Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
- (2014) Judith Müller et al. Nature Communications
- A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors
- (2014) D. J. Konieczkowski et al. Cancer Discovery
- Cytotoxic T Lymphocytes Block Tumor Growth Both by Lytic Activity and IFN -Dependent Cell-Cycle Arrest
- (2014) H. Matsushita et al. Cancer Immunology Research
- IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes
- (2013) D Murtas et al. BRITISH JOURNAL OF CANCER
- Genetic and non-genetic instability in tumor progression: link between the fitness landscape and the epigenetic landscape of cancer cells
- (2013) Sui Huang CANCER AND METASTASIS REVIEWS
- Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells
- (2013) Alexander Roesch et al. CANCER CELL
- BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma
- (2013) D. T. Frederick et al. CLINICAL CANCER RESEARCH
- Resistance to BRAF-targeted therapy in melanoma
- (2013) Ryan J. Sullivan et al. EUROPEAN JOURNAL OF CANCER
- MITF, the Janus transcription factor of melanoma
- (2013) Dana Koludrovic et al. Future Oncology
- Vemurafenib Induces Senescence Features in Melanoma Cells
- (2013) Sebastian Haferkamp et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Stem cells and targeted approaches to melanoma cure
- (2013) George F. Murphy et al. MOLECULAR ASPECTS OF MEDICINE
- T-helper-1-cell cytokines drive cancer into senescence
- (2013) Heidi Braumüller et al. NATURE
- A melanocyte lineage program confers resistance to MAP kinase pathway inhibition
- (2013) Cory M. Johannessen et al. NATURE
- Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
- (2013) Meghna Das Thakur et al. NATURE
- Tumor metastasis: moving new biological insights into the clinic
- (2013) Liling Wan et al. NATURE MEDICINE
- Hypoxia-induced senescence contributes to the regulation of microenvironment in melanomas
- (2013) Jing Mo et al. PATHOLOGY RESEARCH AND PRACTICE
- Imatinib Reverses Doxorubicin Resistance by Affecting Activation of STAT3-Dependent NF-κB and HSP27/p38/AKT Pathways and by Inhibiting ABCB1
- (2013) Jonathan T. Sims et al. PLoS One
- Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
- (2013) S. Spranger et al. Science Translational Medicine
- How to escape the cancer attractor: Rationale and limitations of multi-target drugs
- (2013) Sui Huang et al. SEMINARS IN CANCER BIOLOGY
- Non-Darwinian dynamics in therapy-induced cancer drug resistance
- (2013) Angela Oliveira Pisco et al. Nature Communications
- Clonal competition with alternating dominance in multiple myeloma
- (2012) J. J. Keats et al. BLOOD
- Cancer Stem Cells: Distinct Entities or Dynamically Regulated Phenotypes?
- (2012) Y. Li et al. CANCER RESEARCH
- Interferon-γ-induced activation of Signal Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells
- (2012) Martina J Schmitt et al. Cell Communication and Signaling
- Targeting aurora kinases limits tumour growth through DNA damage-mediated senescence and blockade of NF-κB impairs this drug-induced senescence
- (2012) Yan Liu et al. EMBO Molecular Medicine
- Effect of SMURF2 Targeting on Susceptibility to MEK Inhibitors in Melanoma
- (2012) Michael P. Smith et al. JNCI-Journal of the National Cancer Institute
- Novel synthetic derivatives of the natural product berbamine inhibit Jak2/Stat3 signaling and induce apoptosis of human melanoma cells
- (2012) Sangkil Nam et al. Molecular Oncology
- Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation
- (2012) Jennifer Landsberg et al. NATURE
- Stochastic expression dynamics of a transcription factor revealed by single-molecule noise analysis
- (2012) Zach Hensel et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic classification of melanoma cells by phenotype-specific gene expression mapping
- (2012) Daniel S. Widmer et al. Pigment Cell & Melanoma Research
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
- (2012) J. M. Taube et al. Science Translational Medicine
- Nonheritable Cellular Variability Accelerates the Evolutionary Processes of Cancer
- (2012) Steven A. Frank et al. PLOS BIOLOGY
- Senescent Cells in Growing Tumors: Population Dynamics and Cancer Stem Cells
- (2012) Caterina A. M. La Porta et al. PLoS Computational Biology
- A Requirement of STAT3 DNA Binding Precludes Th-1 Immunostimulatory Gene Expression by NF- B in Tumors
- (2011) H. Lee et al. CANCER RESEARCH
- Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival
- (2011) Jonathan R. Brody et al. CELL CYCLE
- Association of IFN- Signal Transduction Defects with Impaired HLA Class I Antigen Processing in Melanoma Cell Lines
- (2011) A. Respa et al. CLINICAL CANCER RESEARCH
- The Two Faces of Interferon- in Cancer
- (2011) M. R. Zaidi et al. CLINICAL CANCER RESEARCH
- Senescent cells develop a PARP-1 and nuclear factor- B-associated secretome (PNAS)
- (2011) M. Ohanna et al. GENES & DEVELOPMENT
- MHC Class II Engagement by Its Ligand LAG-3 (CD223) Contributes to Melanoma Resistance to Apoptosis
- (2011) P. Hemon et al. JOURNAL OF IMMUNOLOGY
- Fibroblasts Contribute to Melanoma Tumor Growth and Drug Resistance
- (2011) Edward H. Flach et al. MOLECULAR PHARMACEUTICS
- Interferon-γ links ultraviolet radiation to melanomagenesis in mice
- (2011) M. Raza Zaidi et al. NATURE
- A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma
- (2011) Satoru Yokoyama et al. NATURE
- A novel steroidal inhibitor of estrogen-related receptor α (ERRα)
- (2010) Sarah J. Duellman et al. BIOCHEMICAL PHARMACOLOGY
- Interferon limits the effectiveness of melanoma peptide vaccines
- (2010) H.-I. Cho et al. BLOOD
- Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells
- (2010) Gregory B Lesinski et al. BMC CANCER
- Microphthalmia-Associated Transcription Factor Controls the DNA Damage Response and a Lineage-Specific Senescence Program in Melanomas
- (2010) Sandy Giuliano et al. CANCER RESEARCH
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
- (2010) Sreenath V. Sharma et al. CELL
- Cellular Heterogeneity: Do Differences Make a Difference?
- (2010) Steven J. Altschuler et al. CELL
- Tumor-promoting role of signal transducer and activator of transcription (Stat)1 in late-stage melanoma growth
- (2010) Julia Schultz et al. CLINICAL & EXPERIMENTAL METASTASIS
- STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors
- (2010) Heehyoung Lee et al. NATURE MEDICINE
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lighting a path to pigmentation: mechanisms of MITF induction by UV
- (2010) Jue J. Liu et al. Pigment Cell & Melanoma Research
- A proliferative melanoma cell phenotype is responsive to RAF/MEK inhibition independent of BRAF mutation status
- (2010) Marie C. Zipser et al. Pigment Cell & Melanoma Research
- Identification and targeting of cancer stem cells
- (2009) Tobias Schatton et al. BIOESSAYS
- Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors
- (2009) Heehyoung Lee et al. CANCER CELL
- Non-genetic cell-to-cell variability and the consequences for pharmacology
- (2009) Mario Niepel et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis
- (2009) Sabrina L. Spencer et al. NATURE
- Cancer stem cells: mirage or reality?
- (2009) Piyush B Gupta et al. NATURE MEDICINE
- Non-genetic heterogeneity — a mutation-independent driving force for the somatic evolution of tumours
- (2009) Amy Brock et al. NATURE REVIEWS GENETICS
- Cancer attractors: A systems view of tumors from a gene network dynamics and developmental perspective
- (2009) Sui Huang et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- In vivo Switching of Human Melanoma Cells between Proliferative and Invasive States
- (2008) K. S. Hoek et al. CANCER RESEARCH
- Molecular Basis for the Critical Role of Suppressor of Cytokine Signaling-1 in Melanoma Brain Metastasis
- (2008) F.-J. Huang et al. CANCER RESEARCH
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Nature, Nurture, or Chance: Stochastic Gene Expression and Its Consequences
- (2008) Arjun Raj et al. CELL
- Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence
- (2008) Juan C. Acosta et al. CELL
- Dynamic expression of protective CEACAM1 on melanoma cells during specific immune attack
- (2008) Gal Markel et al. IMMUNOLOGY
- Melanoma Stem Cells: The Dark Seed of Melanoma
- (2008) Susan E. Zabierowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of cells initiating human melanomas
- (2008) Tobias Schatton et al. NATURE
- Efficient tumour formation by single human melanoma cells
- (2008) Elsa Quintana et al. NATURE
- Stochasticity and Cell Fate
- (2008) R. Losick et al. SCIENCE
- Dynamic Proteomics of Individual Cancer Cells in Response to a Drug
- (2008) A. A. Cohen et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More